1. Therapeutic Potential of Regorafenib—A Multikinase Inhibitor in Pulmonary Hypertension
   Swathi Veeroju et al, 2021, International Journal of Molecular Sciences CrossRef
2. Neurohormonal modulation in pulmonary arterial hypertension
   Eva L. Peters et al, 2021, European Respiratory Journal CrossRef
3. Effect of sacubitril valsartan on heart failure with mid-range or preserved ejection fraction in patients on maintenance hemodialysis: real-world experience in a single-center, prospective study
   Xiao-mei Huang et al, 2024, BMC Cardiovascular Disorders CrossRef
4. TMEM16A regulates portal vein smooth muscle cell proliferation in portal hypertension
   Xi Zeng et al, 2017, Experimental and Therapeutic Medicine CrossRef
5. Valsartan prevents gefitinib-induced lung inflammation, oxidative stress, and alteration of plasma metabolites in rats
   Wael A. Alanazi et al, 2023, Saudi Journal of Biological Sciences CrossRef
6. The efficacy and safety of Sacubitril/Valsartan on pulmonary hypertension in hemodialysis patients
   Cong Zhao et al, 2022, Frontiers in Medicine CrossRef